Gemcitabine的問題,透過圖書和論文來找解法和答案更準確安心。 我們找到下列懶人包和總整理
Gemcitabine的問題,我們搜遍了碩博士論文和台灣出版的書籍,推薦Abraham, Owen寫的 Pancreatic Cancer: Biology and Alternative Therapies 和Johnson, C. D. (EDT)/ Imrie, C. W. (EDT)的 Pancreatic Disease: Basic Science and Clinical Management都 可以從中找到所需的評價。
另外網站Gemcitabine injection - Cleveland Clinic也說明:GEMCITABINE (jem SYE ta been) is a chemotherapy drug. This medicine is used to treat many types of cancer like breast cancer, lung cancer, pancreatic cancer ...
這兩本書分別來自 和所出版 。
高雄醫學大學 醫學研究所博士班 蔡英美、江博暉、孫昭玲所指導 陳建旭的 程序性死亡配體1表現於上尿路泌尿上皮癌的角色 (2021),提出Gemcitabine關鍵因素是什麼,來自於聯合陽性分數、Ki-67、程序性細胞死亡配體-1、根治性腎輸尿管切除術、上尿路泌尿上皮癌。
而第二篇論文中原大學 生物醫學工程研究所 葛宗融所指導 鄭舜文的 GBP5可作為預測三陰性乳腺癌轉移、PD-L1表達和紫杉醇反應性的潛在生物標誌物 (2021),提出因為有 三陰性乳腺癌的重點而找出了 Gemcitabine的解答。
最後網站Gemcitabine Dosage & Rx Info | Uses, Side Effects - eMPR.com則補充:Gemcitabine Classification: Antimetabolite. Gemcitabine Interactions: Severe radiation toxicity with concomitant radiation therapy: not recommended.
Pancreatic Cancer: Biology and Alternative Therapies
為了解決Gemcitabine 的問題,作者Abraham, Owen 這樣論述:
Pancreatic cancer is a disease in which cancer cells develop from a glandular organ situated behind the stomach known as pancreas. A thorough comprehension of the biology of pancreatic cancer, heredity, complex signaling pathways as well as alternate therapies has been presented in this book. It elu
cidates nutrigenomics and epigenetics mechanisms like DNA methylation, which can enable describing the etiology or progression of pancreatic cancer. It also outlines the molecular control of oncogenic pathways like KLF4 and K-Ras. Since this disease metastasizes to essential organs resulting in poor
prognosis, particular stress has been laid on the mechanism of tumor cell metastasis and invasion. Detailed information regarding the role of Syk kinase and nitric oxide in tumor metastasis has also been presented. Preventive techniques against this disease have also been highlighted. The molecular
mechanisms of the anti-cancer impacts of benzyl isothiocynate, vitamin D and curcumin have also been described comprehensively in this extensive book. It also encompasses the fundamental mechanisms of resistance against this disease and chemotherapy drugs like 5-fluorouracil and gemcitabine. This b
ook will be a valuable account of information to the readers.
Gemcitabine進入發燒排行的影片
程序性死亡配體1表現於上尿路泌尿上皮癌的角色
為了解決Gemcitabine 的問題,作者陳建旭 這樣論述:
背景與研究重點:與西方國家相比,台灣上尿路泌尿上皮癌的發病率相對較高。根治性腎臟及輸尿管全切除術具有治癒器官局限性腫瘤疾病的潛力。然而,局部晚期或轉移性上尿路泌尿上皮癌的預後較差,需要用化學療法或免疫療法進行進一步的輔助或姑息治療以延長生存期。為了及早發現這些高風險的病人,尋找理想、可靠的生物標誌物對上尿路泌尿上皮癌進行預後評估或甚至治療效果評估具有重要意義。程序性死亡配體1 (programmed death-ligand 1, PD-L1) 對膀胱癌的影響已得到充分研究;然而,PD-L1在上尿路泌尿上皮癌中的角色仍不清楚。我們的研究由兩部分組成,第一部分是研究PD-L1對上尿路泌尿上皮癌
臨床結果和預後的影響。在第二部分中,我們嘗試結合其他生物標誌物(Ki-67)來評估在預測上尿路泌尿上皮癌預後中是否存在協同效應。方法:回顧性收集2013年至2018年在高雄長庚紀念醫院確診的上尿路泌尿上皮癌患者。我們僅納入接受根治性腎臟及輸尿管全切除術的患者,排除曾接受過手術前全身治療、診斷時已有轉移或有肌肉浸潤性膀胱癌病史的患者。我們使用Dako 22C3 pharmDx檢驗對全組織切片進行PD-L1免疫組織化學染色,並使用聯合陽性分數 (combined positive score, CPS)來計算PD-L1在腫瘤細胞及免疫細胞中的表現。PD-L1聯合陽性分數小於10定義為陰性表現。在第
二部分中,我們在同一研究族群中使用抗Ki-67抗體進行了Ki-67染色。 Ki-67指數≥20%被定義為過度表現。結果:第一部分共有105名患者符合研究條件而納入分析。在17.1%的上尿路泌尿上皮癌患者中發現PD-L1表現陽性(即CPS ≥ 10)。PD-L1聯合陽性分數≥ 10多見於術前腫瘤分期較高或診斷時已有淋巴結轉移的患者。在多變量分析中,PD-L1聯合陽性分數≥ 10和較高腫瘤期別獨立預測較差的癌症特異性存活期和總存活期。在第二部分中,由於有3名患者缺乏Ki-67染色,因此僅納入102名患者進行分析。在48%的上尿路泌尿上皮癌患者中觀察到Ki-67 ≥ 20%,Ki-67過度表現也與較
高腫瘤期別和不良的病理學特徵相關。在多變量分析中,將單獨的PD-L1、單獨的Ki-67以及PD-L1加上Ki-67的組合納入預測上尿路泌尿上皮癌預後因子的分析中。然而,PD-L1聯合陽性分數 ≥ 10和Ki-67 ≥ 20%的組合無法顯示出比單獨使用PD-L1有更好的癌症特異性存活期預測能力。結論:上尿路泌尿上皮癌患者PD-L1聯合陽性分數≥ 10 或 Ki-67 ≥ 20% 與較差的病理特徵相關。然而,只有PD-L1聯合陽性分數≥ 10是上尿路泌尿上皮癌預後的強預測因子。
Pancreatic Disease: Basic Science and Clinical Management
為了解決Gemcitabine 的問題,作者Johnson, C. D. (EDT)/ Imrie, C. W. (EDT) 這樣論述:
Pancreatic Disease: basic science and clinical management summarises the state of the art in basic science and clinical management of pancreatic disease. This book provides a clear and up-to-date review of the advancing areas in clinical pancreatology and clinical research related to the pancreas
. Written by leading experts in the field, this comprehensive review directs the interested reader towards important and current published source material. Covering all aspects of pancreatic disease, contributions are included from pancreatic surgeons and medical pancreatologists on pancreatic cance
r, acute pancreatitis and chronic pancreatitis. Special features include a systematic review of the evidence for the use of gemcitabine in pancreatic cancer prepared for the National Institute of Clinical Excellence (NICE), the UK body charged with evaluating new drug treatment. Gemcitabine has FDA
approval. There are several contributions dealing with the management of pancreatic neuroendocrine tumours. This book will be useful to gastroenterologists, internists and surgeons, and specialist clinicians with an interest in pancreatic disease. Trainees in medical and surgical pancreatology will
find it a companion to supplement standard textbooks.
GBP5可作為預測三陰性乳腺癌轉移、PD-L1表達和紫杉醇反應性的潛在生物標誌物
為了解決Gemcitabine 的問題,作者鄭舜文 這樣論述:
三陰性乳腺癌(TNBC)具有乳腺癌亞型分子異質性的特點,對內分泌治療不敏感,化療方案選擇困難。由於其高轉移潛力和缺乏標準化的 TNBC 治療方案,它已成為最具侵襲性的乳腺癌類型。免疫細胞上程序性細胞死亡配體 1 (PD-L1) 的異常高表達誘導轉移性 TNBC 中的免疫逃避,並與 pCR 顯著相關。儘管如此,TNBC中轉移進展和PD-L1上調的機制仍有許多未知數。該實驗發現,與非 TNBC 和正常乳腺組織相比,GBP,尤其是 GBP5 在 TNBC 組織中的水平特別高,並且在乳腺癌患者中充當不良預後標誌物。細胞遷移測定培養物表明,GBP5 表達的上調與 TNBC 細胞中的細胞遷移能力有因果關
係。此外,GBP5 敲低還抑制了 IFN-γ/STAT1 和 TNF-α/NF-κB 信號軸的活性以及 PD-L1 的表達。我們還發現,較高的 GBP5 水平預示著乳腺癌患者腦轉移的時間間隔較短。由於三陰性乳腺癌(TNBC)缺乏激素受體表達,化療仍然是一線全身治療。新輔助或輔助紫杉烷類藥物仍然是三陰性乳腺癌化療的中流砥柱。然而,仍然沒有有效的生物標誌物來預測 TNBC 患者對紫杉烷類化療的反應和療效。我們發現 GBP5 的表達與 TNBC 細胞系中紫杉醇的 50% 抑制濃度 (IC50) 呈負相關。相反與多柔比星的50%抑制濃度(IC50)呈正相關。在接受新輔助或輔助化療的 TNBC 患者中,
較高的 GBP5 水平強烈預示著良好的反應。通過基因集富集分析 (GSEA) 程序對 GBP5 特徵的計算模擬表明,GBP5 與 TNBC 中其他體細胞基因的共表達表明,GBP5 上調可能與乾擾素 γ (IFN-γ) 反應性和 NF-κB 相關發信號。它還可以通過激活 Akt/mTOR 信號軸和抑制癌細胞中的自噬來增強紫杉醇的細胞毒作用。這些發現不僅暗示了 GBP5 的致癌功能,而且還提供了一種通過靶向 GBP5 活性來治療轉移性和免疫抑制性 TNBC 的新方法。
想知道Gemcitabine更多一定要看下面主題
Gemcitabine的網路口碑排行榜
-
#1.吉西他滨_百度百科
吉西他滨(Gemcitabine),为一种新的胞嘧啶核苷衍生物,化学式为C9H11F2N3O4。和阿糖胞苷一样,进入人体内后由脱氧胞嘧啶激酶活化,由胞嘧啶核苷脱氨酶代谢。 於 baike.baidu.com -
#2.Gemcitabine - APExBIO
Gemcitabine is a DNA synthesis inhibitor with anti-tumor activity. In human osteosarcoma cell lines HOS and MG63, gemcitabine inhibited DNA synthesis and ... 於 www.apexbt.com -
#3.Gemcitabine injection - Cleveland Clinic
GEMCITABINE (jem SYE ta been) is a chemotherapy drug. This medicine is used to treat many types of cancer like breast cancer, lung cancer, pancreatic cancer ... 於 my.clevelandclinic.org -
#4.Gemcitabine Dosage & Rx Info | Uses, Side Effects - eMPR.com
Gemcitabine Classification: Antimetabolite. Gemcitabine Interactions: Severe radiation toxicity with concomitant radiation therapy: not recommended. 於 www.empr.com -
#5.認識化療藥品Gemcitabine | 衛教單張 - 中國醫藥大學附設醫院
本品是一種抗癌藥,單獨使用或與其他藥品併用,用於治療非小細胞肺癌、胰臟癌、膀胱癌、乳癌、卵巢癌等。 於 www.cmuh.cmu.edu.tw -
#6.dd-MVAC vs Gemcitabine/Cisplatin for Muscle-Invasive ...
dd-MVAC vs Gemcitabine/Cisplatin for Muscle-Invasive Bladder Cancer ... treatment regimens—gemcitabine/cisplatin or dose-dense methotrexate, ... 於 ascopost.com -
#7.Gemzar ® (gemcitabine for injection) - Lilly Medical
Gemzar is used for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and pancreatic cancer. 於 www.lillymedical.com -
#8.Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce ...
... Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation. 2009/7/30. Eli Lilly & Company ("Lilly") and ScinoPharm Taiwan Ltd. 於 www.scinopharm.com -
#9.Gemcitabine (Gemzar) - Chemotherapy Drug for ...
Gemcitabine is a chemotherapy drug used to treat mesothelioma and other forms of cancer, such as non-small cell lung cancer and soft-tissue ... 於 www.mesotheliomahope.com -
#10.Mechanism of action of gemcitabine 1 - ResearchGate
Download scientific diagram | Mechanism of action of gemcitabine 1 . from publication: Comparative in vitro Cytotoxicity of the Generic and Reference ... 於 www.researchgate.net -
#11.Gemcitabine Hydrochloride - National Cancer Institute
Use in Cancer · Breast cancer that cannot be treated with or that did not respond to chemotherapy that included an anthracycline drug. · Non-small ... 於 www.cancer.gov -
#12.Gemcitabine (吉西他濱) - 癌症資訊網
Gemcitabine (吉西他濱) · 1. 此藥可與Cisplatin一起使用於非小細胞肺癌治療上。 · 2. Gemcitabine 對治療膀胱癌的療效與Cisplatin相約,但毒性較少。 · 3. 於 cancerinformation.com.hk -
#13.Mosby's Drug Reference for Health Professions - E-Book
Gemcitabine undergoes intracellular conversion to gemcitabine monophosphate via the enzyme deoxycytidine kinase. Gemcitabine monophosphate is subsequently ... 於 books.google.com.tw -
#14.認識化療藥品Gemcitabine - 中國醫藥大學附設醫院國際醫療中心
Gemcitabine (Gemzar) 為無菌凍晶粉末製劑,每瓶200 毫克。靜脈注射用。 常見副作用. 噁心、嘔吐:此症狀輕微,可以止吐劑改善。 於 ims.cmuh.org.tw -
#15.Gemcitabine (Intravenous Route) Description and Brand Names
Gemcitabine injection is used together with other medicines (eg, carboplatin) to treat patients with advanced ovarian cancer that has come back at least 6 ... 於 www.mayoclinic.org -
#16.The American Cancer Society's Oncology in Practice: Clinical ...
5‐FU, 5‐Fluorouracil; Gem, gemcitabine; Ox, oxalaplatin; Cis, cisplatin. respectively for 5‐FU and 78.5% and 48.1% for patients treated with gemcitabine ... 於 books.google.com.tw -
#17.健仕平山德士40毫克/毫升注射劑的功效 - 康健知識庫
Gemcitabine Sandoz 40mg/ml Concentrate for Solution for Infusion,點擊看用法用量及副作用。適應症:非小細胞肺癌、胰臟癌、膀胱癌。GEMCITABINE與PACLITAXEL併用 ... 於 kb.commonhealth.com.tw -
#18.Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine ...
Gemcitabine has been studied as a single agent for the treatment of metastatic bladder cancer. These studies demonstrate that single-agent ... 於 ascopubs.org -
#19.Gemcitabine Pathway, Pharmacokinetics/Pharmacodynamics
Gemcitabine is a hydrophilic molecule, and three nucleoside transporters mediate most of its uptake into cells: SLC29A1 SLC28A1, and SLC28A3. Gemcitabine is ... 於 www.pharmgkb.org -
#20.GEMCITABINE HYDROCHLORIDE-藥品(物)/適應症/副作用查詢
非小細胞肺癌。 2.胰臟癌。 3.膀胱癌。 4.Gemcitabine與paclitaxel併用,可使用於曾經使用過anthracycline之局部復發且無法手術切除或轉移性之乳癌病 ... 於 www.kingnet.com.tw -
#21.Gemcite (Gemcitabine) - South Delhi Pharma
Gemcitabine, sold under the brand name Gemzar, among others, is a chemotherapy medication used to treat a number of types of cancer. These ... 於 www.southdelhipharma.com -
#22.Gemcitabine - an overview | ScienceDirect Topics
Gemcitabine (Gemzar, Eli Lilly, Indianapolis, IN) is a nucleoside analog that replaces cytidine during DNA replication. This process arrests tumor growth, ... 於 www.sciencedirect.com -
#23.Gemcitabine hydrochloride ≥98% (HPLC) | 122111-03-9
Gemcitabine -Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer. Jun Young Park et al. ... Gemcitabine has been considered a first- ... 於 www.sigmaaldrich.com -
#24.Gemcitabine: Uses, Interactions, Mechanism of Action
Gemcitabine is a nucleoside analog and a chemotherapeutic agent. It was originally investigated for its antiviral effects, but it is now used as an anticancer ... 於 go.drugbank.com -
#25.Gemcitabine (Gemzar) | UPMC Hillman Cancer Center
Gemcitabine (Gemzar) is given intravenously (IV) to treat cancer. Find side effects, allergic reactions, and food and drug interactions. 於 hillman.upmc.com -
#26.a randomised, double-blind, placebo-controlled, phase 2 trial
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo ... 於 www.thelancet.com -
#27.Gemcitabine versus Modified Gemcitabine: A Review of ...
Gemcitabine, an anticancer agent which acts against a wide range of solid tumors, is known to be rapidly deaminated in blood to the inactive ... 於 pubs.acs.org -
#28.Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus ...
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas. The safety and scientific ... 於 clinicaltrials.gov -
#29.Gemcitabine Uses, Side Effects & Warnings - Drugs.com
Gemcitabine is used to treat cancers of the pancreas, lung, ovary, and breast. Gemcitabine is sometimes given with other cancer medicines, or ... 於 www.drugs.com -
#30.Devimistat With Gemcitabine and Cisplatin Advances to ...
The phase 1b BilT-04 study of devimistat (CPI-613) in combination with gemcitabine and cisplatin to treat patients with biliary tract cancer ... 於 www.targetedonc.com -
#31.GEMCITABINE - INJECTION (Gemzar) side effects, medical ...
Consumer information about the medication GEMCITABINE - INJECTION (Gemzar), includes side effects, drug interactions, recommended dosages, ... 於 www.medicinenet.com -
#32.gemcitabine | Ligand page - IUPHAR/BPS Guide to ...
Comment: Gemcitabine is a nucleoside analogue chemotherapeutic. Chemically, the hydrogen atoms on the 2' carbon of deoxycytidine are replaced by fluorine ... 於 www.guidetopharmacology.org -
#33.Gemcitabine - Chemotherapy Drugs - Chemocare
Drug Type: Gemcitabine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Gemcitabine is classified as an antimetabolite. (For more detail ... 於 chemocare.com -
#34.Gemcitabine (Gemzar®) & Mesothelioma | Chemotherapy Drug
Gemcitabine is a chemotherapy drug that has shown some success in mesothelioma clinical trials. Find out more about side effects, uses and studies ... 於 www.mesothelioma.com -
#35.Multimodality Management of Borderline Resectable Pancreatic ...
overall survival when compared to gemcitabine alone (HR = 0.82, p=0.038). However, the benefit was deemed clinically less meaningful because of a very ... 於 books.google.com.tw -
#36.Gemcitabine chemoresistance and molecular markers ...
Furthermore, the expression ratio significantly correlated with gemcitabine sensitivity in eight pancreatic cancer cell lines, whereas no single ... 於 www.nature.com -
#37.Presentation During New Advances in the Management of ...
RenovoRx has been granted Orphan Drug Designation for intra-arterial delivery of gemcitabine for the treatment of both pancreatic cancer and ... 於 www.businesswire.com -
#38.Gemcitabine | Medicines | Living Beyond Breast Cancer
Gemcitabine is one term to know when learning about breast cancer, & is a medicine used in combination with other agents to treat breast ... 於 www.lbbc.org -
#39.PA 1634 AMP GEMZAR® (GEMCITABINE HCl) FOR ...
Gemcitabine demonstrated dose-dependent synergistic activity with cisplatin in vitro. No effect of cisplatin on gemcitabine triphosphate accumulation or DNA ... 於 www.accessdata.fda.gov -
#40.Gemcitabine : substance active à effet thérapeutique - VIDAL
La gemcitabine est un antimétabolique spécifique de la phase S du cycle cellulaire, phase de synthèse de l'ADN (acide désoxyribonucléique). Elle ... 於 www.vidal.fr -
#41.LncRNA PVT1 promotes gemcitabine resistance of pancreatic ...
Blockade of autophagy with chloroquine also significantly increased the sensitivity of pancreatic cancer cells to gemcitabine [15]. The Wnt/β- ... 於 molecular-cancer.biomedcentral.com -
#42.Gemzar | European Medicines Agency - europa.eu
Table of contents · Overview · Opinion following an Article 30 referral for Gemzar and associated names International Non-Proprietary Name (INN): gemcitabine: ... 於 www.ema.europa.eu -
#43.Cisplatin plus Gemcitabine versus Gemcitabine for Biliary ...
Background There is no established standard chemotherapy for patients with locally advanced or metastatic biliary tract cancer. 於 www.nejm.org -
#44.Gemcitabine HCL Market Outlook to 2030 - Medgadget
Gemcitabine HCL (hydrochloride) is basically a chemical compound used majorly for treating different types of cancers. 於 www.medgadget.com -
#45.Dose-Dense MVAC Versus Gemcitabine/Cisplatin for ...
Dose-Dense MVAC Versus Gemcitabine/Cisplatin for Preoperative Treatment of Muscle-Invasive Bladder Cancer. Interview by: Aman Shah MD ... 於 www.practiceupdate.com -
#46.Local Delivery of Gemcitabine Inhibits Pancreatic and ... - MDPI
Gemcitabine is clinically used to treat certain types of cancers, including pancreatic and biliary cancer. We investigated the signal transduction pathways ... 於 www.mdpi.com -
#47.認識化療藥品Gemcitabine - 亞洲大學附屬醫院
Gemcitabine (Gemzar) 為無菌凍晶粉末製劑,每瓶200 毫克。靜脈注射用。 ... 噁心、嘔吐:此症狀輕微,可以止吐劑改善。 白血球、血小板減少:骨髓抑制通常是輕至中度;此 ... 於 www.auh.org.tw -
#48.Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment ...
This open-label, single-arm, phase 2 clinical trial evaluates whether nab-paclitaxel plus gemcitabine-cisplatin prolongs survival vs that ... 於 jamanetwork.com -
#49.Gemcitabine (Gemzar®) | OncoLink
Gemcitabine is a chemotherapy medication used in the treatment of ovarian cancer, breast, non small cell lung cancer, and pancreatic cancer. 於 www.oncolink.org -
#50.【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General Hospital
Gemcitabine (dFdc)在細胞內被核苷激酶代謝成具有活性的雙磷酸鹽(dFdCDP)及三磷酸鹽(dFdCTP)核苷,因抑制DNA的生合成,而產生細胞毒性之作用。此作用機轉包括兩個步驟:首先 ... 於 www.ktgh.com.tw -
#51.Gemcitabine (Gemzar) | Cancer information - Cancer ...
Gemcitabine is a type of chemotherapy drug. You might have it as a treatment for a number of different cancers, including bladder and breast cancer. 於 www.cancerresearchuk.org -
#52.Lymphoma GDP (gemcitabine dexamethasone ciSplatin) - eviQ
Gemcitabine is a cytarabine analogue which has synergistic activity with cisplatin in vitro. These two agents, along with the dexamethasone dose used in DHAP ... 於 www.eviq.org.au -
#53.健擇®注射劑GEMZAR
Gemcitabine 用於緩和治療局部晚期或轉移性非小細胞肺癌成人病人。 ... 乳癌─ Gemcitabine 與paclitaxel 併用,可使用於曾經使用過anthracycline 之局部復發且無. 於 www1.ndmctsgh.edu.tw -
#54.Gemcitabine (Gemzar) - Children's Minnesota
Gemcitabine (Gemzar). How does this medicine work? Gemcitabine (jem-cy-ta-bean) destroys cancer cells in all phases of cell life. 於 www.childrensmn.org -
#55.Gemcitabine (Gemzar) - Breast Cancer Now
Read about the the chemotherapy drug gemcitabine, also known as Gemzar, including information about side effects. 於 breastcancernow.org -
#56.健擇注射劑 - 華人癌症資訊網
中文名稱:健擇注射劑英文名稱:Gemcitabine HCl藥品:Gemzar藥品分類:化學治療藥物仿單適應症: 非小細胞肺癌、胰臟癌、膀胱癌。GEMCITABINE與PACLITAXEL併用, ... 於 www.tci-mandarin.com -
#57.Gemcitabine | CancerQuest
Usage: Malignancies for which gemcitabine is used include non-small cell lung cancer (in combination with cisplatin), pancreatic cancer (advanced or metastatic ... 於 www.cancerquest.org -
#58.Oxford Textbook of Oncology - 第 496 頁 - Google 圖書結果
Although there is no doubt that this combination is superior to gemcitabine (and gemcitabine-containing regimens investigated to date), the potential ... 於 books.google.com.tw -
#59.Role of gemcitabine in cancer therapy | Future Oncology
Gemcitabine, a pyrimidine nucleoside antimetabolite, is one of the most promising new cytotoxic agents. The drug has shown activity in a variety of solid ... 於 www.futuremedicine.com -
#60.Gemcitabine for Injection, USP - Meitheal Pharmaceuticals
Gemcitabine for Injection, USP 200 mg per vial. Unit of Sale NDC 71288-113-10; Unit of Use NDC 71288-113-10; Container Type SD Glass Vial ... 於 www.meithealpharma.com -
#61.GA/GemNab: Gemcitabine and Nab-paclitaxel (Abraxane®)
Your chemotherapy regimen consists of two medicines. One is called gemcitabine and the other is called nab ... 於 www.youtube.com -
#62.健仕Gemcitabine 200mg/6mL vial - 馬偕紀念醫院民眾用藥資訊 ...
Gemcitabine 是一種抗癌藥,單獨使用或與其他藥品併用,用於治療非小細胞. 肺癌、胰臟癌、膀胱癌、乳癌、卵巢癌。 □服藥時之注意事項:. 於 ttw3.mmh.org.tw -
#63.處方明細資料 - 國軍高雄總醫院-用藥指導-內容
商品名. GEMITA LYOPHILIZED INJ. 【200 MG】Vial △. 商品中文名. 健彌達靜脈凍晶注射劑△. 學名. GEMCITABINE HYDROCHL. 廠牌. 台灣費森尤斯卡比. 於 802.mnd.gov.tw -
#64.Role of gemcitabine in cancer therapy - PubMed
Gemcitabine, a pyrimidine nucleoside antimetabolite, is one of the most promising new cytotoxic agents. The drug has shown activity in a variety of solid ... 於 pubmed.ncbi.nlm.nih.gov -
#65.化療藥品衛教單張(民眾版) 健仕注射液(Gemcitabine)
三、副作用:噁心、腹瀉、骨髓抑制、皮膚疹、周邊性水腫、掉髮。 四、注意事項:. ○ 病患使用Gemcitabine 治療時應每隔一週檢查血小板、. ,白血球的數目, ... 於 211.22.100.22 -
#66.Gemcitabine and cisplatin for metastatic urothelial cancer
Cycle length: 28 days. Total cycles: Maximum of 6 cycles.*. Drug, Dose and route, Administration, Given on days. Gemcitabine, 1000 mg/m 2 IV ... 於 www.uptodate.com -
#67.gemcitabine - Farmacotherapeutisch Kompas
Bij gemcitabine betreft het in het merendeel van de gevallen de mucosa (bv. van oesofagus, colon, longen) en in mindere mate de huid. Voor behandeling van ... 於 www.farmacotherapeutischkompas.nl -
#68.Fixed-dose-rate infusion and novel agents - International ...
Abstract. Purpose. To review the use of gemcitabine-based therapy in pancreatic cancer, including fixed-dose-rate (FDR) infusion ... 於 www.redjournal.org -
#69.乳房腫瘤外科Gemcitabine - 臺中 - 台中榮總
Gemcitabine (如Gemzar):(92/12/1、93/8/1、94/10/1、96/5/1、99/10/1、105/2/1) 限用於: 1.晚期或無法手術切除之非小細胞肺癌及胰臟癌病患。 於 www.vghtc.gov.tw -
#70.GEMCITABINE ACCORD 100 mg/ml, solution à diluer pour ...
La gemcitabine est indiquée dans le traitement du carcinome épithélial de l'ovaire localement avancé ou métastatique, en association avec le ... 於 base-donnees-publique.medicaments.gouv.fr -
#71.gemcitabine | Cancer Care Ontario
gemcitabine. ( jem-SITE-a-been ). Funding: New Drug Funding Program. Gemcitabine - Carcinoma of Bladder or Urothelium; Gemcitabine - Non-Small Cell Lung ... 於 www.cancercareontario.ca -
#72.健達必注射劑 - 輝瑞大藥廠
1. 適應症. ○ 非小細胞肺癌. ○ 胰臟癌. ○ 膀胱癌. ○ Gemcitabine與paclitaxel併用,可使用於曾經使用過anthracycline之局部復發. 且無法手術切除或轉移性之乳癌病患。 於 www.pfizer.com.tw -
#73.The Efficacy of Gemcitabine as Salvage Treatment in Patients ...
Objective: To assess the efficacy of gemcitabine based chemotherapy in heavily pre-treated patients with advanced colorectal cancer. Patients and Methods: ... 於 ar.iiarjournals.org -
#74.Gemcitabine - Wikipedia
Gemcitabine is a chemotherapy drug that works by killing any cells that are dividing. ... Cancer cells divide rapidly and so are targeted at higher rates by ... 於 en.wikipedia.org -
#75.Gemcitabine - How it's Used to Treat Mesothelioma & Side ...
The chemotherapeutic drug gemcitabine is most often used to treat pancreatic, ovarian and breast cancers. Doctors also found success in the ... 於 www.asbestos.com -
#76.Gemcitabine (Gemzar®) - Macmillan Cancer Support
Gemcitabine is used to treat cancers of the bladder, pancreas, ovary and breast, and non-small cell lung cancer. 於 www.macmillan.org.uk -
#77.Gemcitabine - IndiaMART
Shree Jee Pharma - Offering gemcitabine, जेमसीटाबाइन इंजेक्शन, Pharmaceutical Injections in Rohini, New Delhi, Delhi. Read about company. 於 www.indiamart.com -
#78.Establishment and characterization of the gemcitabine ...
Gemcitabine (GEM), which is a first-line drug for the treatment of pancreatic cancer, has been reported to improve the therapeutic efficacy and ... 於 www.spandidos-publications.com -
#79.Gemcitabine HCl (Gemzar) - AdooQ® Bioscience
Gemcitabine (Gemzar) is a newer chemotherapy drug acting by replacing one of the building blocks of nucleic acids during DNA replication in cancer cells, ... 於 www.adooq.com -
#80.DRUG NAME: Gemcitabine - BC Cancer
Neoadjuvant cisplatin/gemcitabine combination for locally advanced cervix carcinoma. Proceedings of the American Society of Clinical Oncology 2000;19:399a ( ... 於 www.bccancer.bc.ca -
#81.GEMCITABINE | Drug | BNF content published by NICE
Treatment of metastatic breast cancer which has relapsed after previous chemotherapy including an anthracycline (in combination with paclitaxel). By intravenous ... 於 bnf.nice.org.uk -
#82.Gemcitabine HCL Vial - Uses, Side Effects, and More - WebMD
Gemcitabine is used to treat certain types of cancer (including breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or ... 於 www.webmd.com -
#83.Gemcitabine Injection: MedlinePlus Drug Information
Gemcitabine is also used to treat pancreatic cancer that has spread to other parts of the body and has not improved or worsened after treatment with another ... 於 medlineplus.gov -
#84.化學藥物:Gemzar (gemcitabine HCl) - 護理人學習網- 痞客邦
目前, Gemcitabine核准用於非小細胞肺癌和胰臟癌。在第三期的臨床研究中, Gemcitabine對局部晚期或轉移性胰臟癌有意義地改善病人的症狀和生活品質。 於 g455092001.pixnet.net -
#85.gemcitabine | Apotheek.nl
Gemcitabine remt kanker (cytostaticum). · Bij kanker van longen, alvleesklier, blaas, borsten en eierstokken. · U krijgt dit medicijn als infuus in het ziekenhuis ... 於 www.apotheek.nl -
#86.Gemcitabine | Memorial Sloan Kettering Cancer Center
Gemcitabine. Adult Medication. Share. Print. This information from Lexicomp ® explains what you need to know about this medication, ... 於 www.mskcc.org -
#87.Gemcitabine (Gemzar®) - Pancreatic Cancer UK
Gemcitabine is one of the main chemotherapy drugs used to treat pancreatic cancer. It can be given on its own, or with another chemotherapy drug called ... 於 www.pancreaticcancer.org.uk -
#88.Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For ...
Home » Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fibrolamellar Carcinoma: Promising Results in First 16 Patients ... 於 fibrofoundation.org -
#89.gemcitabine (Rx) - Medscape Reference
USES: Gemcitabine is used to treat certain types of cancer (including breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or ... 於 reference.medscape.com -
#90.Topics in the Surgery of the Biliary Tree - 第 43 頁 - Google 圖書結果
http://dx.doi.org/10.5772/intechopen.76134 gemcitabine, and oxaliplatin combination demonstrated 63% of objective response rate (10% of complete response ... 於 books.google.com.tw -
#91.GEMCIKAL BRANDED Mekanisme kerja - KalbeMed
Gemcitabine sebagai prodrug akan mengalami metabolisme menjadi gemcitabine difosfat dan trifosfat. Gemcitabine difosfat menghambat enzim ribonucleotide ... 於 www.kalbemed.com -
#92.Gemcitabine - Injection | HealthLink BC
Gemcitabine is used to treat certain types of cancer (including breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or ... 於 www.healthlinkbc.ca -
#93.Gemcitabine (LY-188011) | ≥99%(HPLC) - Selleck Chemicals
Gemcitabine (Gemzar) belongs to the group of medicines called antimetabolites. Find all the information about Gemcitabine(Gemzar) for cell ... 於 www.selleckchem.com -
#94.Gemcitabine (Gemzar) - Side Effects, Interactions, Uses ...
Gemcitabine is used to treat cancers of the pancreas, lung, ovary, and breast. Gemcitabine is sometimes given with other cancer medicines, ... 於 www.everydayhealth.com -
#95.Gemzar (Gemcitabine Hcl): Uses, Dosage, Side Effects ...
Gemzar (Gemcitabine Hcl) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug ... 於 www.rxlist.com -
#96.gemzar.pdf - Eli Lilly
GEMZAR safely and effectively. See full prescribing information for GEMZAR. GEMZAR (gemcitabine) for injection, for intravenous use. 於 pi.lilly.com -
#97.健擇注射劑(Gemcitabine) | 醫療財團法人辜公亮基金會和信治癌 ...
健擇注射劑(Gemcitabine) ... 作用機轉:毒殺破壞癌細胞,促使它們死亡。 給藥方式:靜脈注射。 注意事項及常見或嚴重副作用:. 致吐 ... 於 official.kfsyscc.org -
#98.Gemcitabine 10 mg/ml, solution for infusion
Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer ( ... 於 www.medicines.org.uk